Creating a Better, Healthier Community

Take a closer look at Gilead's logo, which features a shield and a leaf. The shield symbolizes our commitment to proud scientific research, the foundation upon which we develop innovative drugs to combat life-threatening diseases. The leaf, representing healing, reflects our ultimate goal: to create a better and healthier world for all people.

Gilead Sciences was founded in 1987 in the San Francisco Bay Area, focusing on antiviral drug development. In 2001, we achieved our first approval for an HIV therapy, paving the way for our ongoing breakthroughs and successes in this field. Since 2013, we have also provided treatments for hepatitis B and a cure for hepatitis C, maintaining our innovative spirit. Today, we are leveraging our accumulated knowledge in antiviral therapies to address COVID-19 and cancer treatments, driven by our deep understanding of human immunology.

In 2014 and 2015, we established offices in Hong Kong and Singapore, where we have attracted some of the best talent in both markets. These teams share our commitment to innovation, patient advocacy, and health equity. By closely collaborating with governments, experts, scholars, communities, and patient organizations, our employees have built a culture of excellence through a shared dedication to our mission to create possible and make our community a healthier place.

Hong Kong and Singapore play crucial roles in our vision to eliminate diseases such as HIV, viral hepatitis, and COVID-19, while also leading the charge in oncology innovation in the region. We take immense pride in the achievements of the Gilead team. With a strong foundation and a diverse culture of home-grown talent, we will continue to our partners to deliver innovative therapies and strive for a healthier community in both markets.